Glioblastoma erodes skull and disrupts immune system, study reveals

October 07, 2025 An Ruwaito ta hanyar AI

Researchers have discovered that glioblastoma, the most aggressive form of brain cancer, extends beyond the brain by eroding the skull and altering the immune cells in skull marrow. This interaction fuels the cancer's progression and explains why current treatments often fail. The findings, published in Nature Neuroscience, suggest new strategies targeting both brain and bone.

Tumor DNA Detection Improves Cancer Screening

September 09, 2025 An Ruwaito ta hanyar AI

Researchers detected tiny tumor DNA fragments in blood, enabling more sensitive cancer screening. The breakthrough was shared on September 5, 2025. This could lead to earlier diagnoses.

Cellular switch discovery offers hope for Parkinson's treatment

Scientists have identified a key cellular regulator called PP2A-B55alpha that balances mitochondrial health, potentially leading to new therapies for Parkinson's disease. In preclinical models, reducing its activity improved motor symptoms and mitochondrial function. The findings, published in Science Advances, could extend to other mitochondrial disorders and cancer.

Study links influenza infection to increased UTI risk

October 04, 2025 An Ruwaito ta hanyar AI

A recent study has found that influenza infections are associated with a doubled risk of urinary tract infections in adults. Researchers analyzed data from thousands of patients to uncover this connection. The findings highlight potential vulnerabilities during flu season.

Blood test identifies Parkinson's years before symptoms

Scientists have developed a blood-based test that detects Parkinson's disease up to seven years before the onset of symptoms. The test targets abnormal alpha-synuclein proteins and shows high accuracy in at-risk individuals. This breakthrough could enable earlier treatments to slow disease progression.